HMD Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$4,303,618.56
Insider Selling (Last 12 Months): A$0.00

HeraMED Insider Trading History Chart

This chart shows the insider buying and selling history at HeraMED by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

HeraMED Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for HMD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

HeraMED Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/7/2021David GrobermanInsiderBuy463,752A$9.28A$4,303,618.56
8/3/2020Ronald (Ron) WeinbergerInsiderBuy286,000A$0.09A$26,884.00
7/20/2020David HintonInsiderBuy333,333A$0.09A$29,999.97
11/28/2019Tal SlonimInsiderIssued1,249,695A$0.19A$231,193.58
See Full Table

SEC Filings (Institutional Ownership Changes) for HeraMED (ASX:HMD)

HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a digital pregnancy monitor platform for the creation and implementation of digital health solutions for maternity care management. It also develops EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is headquartered in Netanya, Israel.
Read More on HeraMED

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A


98,572 shs

Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of HeraMED?

HeraMED's top insider investors include:
  1. David Groberman (Insider)
Learn More about top insider investors at HeraMED.